CSBR:NASDAQ
Champions Oncology Inc
$4.88
arrow_upward
+1.98%(+0.095) 1D
Nov 9, 12:53:49 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.94
High
$4.94
Low
$4.88
Mkt. cap
67.99M
Avg. vol.
9.27K
Volume
1.40K
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.94
High
$4.94
Low
$4.88
Mkt. cap
67.99M
Avg. vol.
9.27K
Volume
1.40K
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
24/7 Wall St.
·
18 minutes ago
Verizon’s Dividends Kept $1,000 Afloat at $1,580 While the S&P 500 Reached $3,910
TradingView
·
1 hour ago
QUICK SPARK: Nvidia Stock Eyes Worst Day Against S&P 500 Since DeepSeek's Shock
ChartMill
·
1 hour ago
S&P 500 Top Movers: Today's US Session Gainers and Losers
StoneX
·
2 hours ago
S&P 500 Forecast: SPX rises despite Nvidia’s decline
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com